Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for epipodophyllotoxin (compound)
Most Correlated Studies
- Etoposide-treated HEK293 cells expressing p65 wt or p65 S547A non-phosphorylable mutant
- Diffuse large B cell lymphomas from brains of primary CNS lymphoma patients
- Rhabdomyosarcoma xenografts treated with ICE-T (ifosfamide, carboplatin, etoposide and paclitaxel)
- Diffuse Large B-Cell Lymphoma OCI-LY3 cells time-course/dose response treatment with 14 drug panel
- Primary hepatocytes treated with non-genotoxic carcinogens or non-carcinogens
Most Relevant Literature
- Chemistry and Biology of Podophyllotoxins: An Update.
- Advances of podophyllotoxin and its derivatives: Patterns and mechanisms.
- Podophyllotoxin derivatives targeting tubulin: An update (2017-2022).
- Podophyllotoxin-mediated neurotoxicity via the microbiota-gut-brain axis in SD rats based on the tox…
- Enhanced podophyllotoxin production of endophyte Fusarium proliferatum TQN5T by host extract and phe…
Most Relevant Clinical Trials
- Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients …
- A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell…
- Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in P…
- Improving Comprehensive Care of Cancer Patients
- High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSC…
